TWO SIGMA ADVISERS, LP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 114 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 45.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,271
+109.2%
24,400
+16.2%
0.00%
Q2 2023$3,476
-84.8%
21,000
-10.3%
0.00%
Q1 2023$22,838
-67.7%
23,400
-65.5%
0.00%
Q4 2022$70,616
-32.1%
67,900
-25.1%
0.00%
Q3 2022$104,000
-62.6%
90,700
-38.9%
0.00%
-100.0%
Q2 2022$278,000
-77.6%
148,500
-63.7%
0.00%
-66.7%
Q1 2022$1,239,000
-69.6%
409,000
-62.1%
0.00%
-70.0%
Q4 2021$4,078,000
-29.2%
1,078,900
-3.2%
0.01%
-33.3%
Q3 2021$5,763,000
+8016.9%
1,114,700
+3938.8%
0.02%
Q1 2021$71,000
-29.0%
27,600
-31.2%
0.00%
Q4 2020$100,0000.0%40,100
-16.8%
0.00%
Q3 2020$100,000
-71.3%
48,200
-57.1%
0.00%
-100.0%
Q2 2020$348,000
+49.4%
112,300
+9.8%
0.00%0.0%
Q1 2020$233,000
-40.6%
102,300
-5.5%
0.00%0.0%
Q4 2019$392,000
-1.3%
108,200
-7.1%
0.00%0.0%
Q3 2019$397,000
-29.6%
116,500
-2.9%
0.00%0.0%
Q2 2019$564,000
+39.6%
120,000
-0.6%
0.00%0.0%
Q1 2019$404,000
+24.3%
120,700
-1.1%
0.00%0.0%
Q4 2018$325,000
-52.1%
122,100
+0.9%
0.00%
-50.0%
Q3 2018$678,000
+13.6%
121,000
+2.7%
0.00%0.0%
Q2 2018$597,000
-10.0%
117,800
+21.2%
0.00%0.0%
Q1 2018$663,000
+125.5%
97,200
+149.5%
0.00%
+100.0%
Q4 2017$294,00038,9510.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders